Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China
· Delayed Price · Currency is CNY 29.14
+0.73 (2.57%)
At close: Mar 10, 2026
SHE:301089 Market Cap
SHE:301089 has a market cap or net worth of 3.69 billion as of March 10, 2026. Its market cap has increased by 1.89% in one year.
Market Cap
3.69B
Enterprise Value
3.44B
Revenue
367.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.14
Market Cap Chart
Since October 27, 2021, SHE:301089's market cap has increased from 3.63B to 3.69B, an increase of 1.55%. That is a compound annual growth rate of 0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3.60B | 1.46% |
| Dec 31, 2025 | 3.54B | -0.67% |
| Dec 31, 2024 | 3.57B | -47.81% |
| Dec 29, 2023 | 6.83B | -24.66% |
| Dec 30, 2022 | 9.07B | -10.45% |
| Dec 31, 2021 | 10.13B | 178.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Well Pharmaceutical Group | 3.60B |
| Anhui Sunhere Pharmaceutical Excipients | 3.58B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 3.62B |
| Zhejiang Cheng Yi Pharmaceutical | 3.64B |
| Hunan Hansen Pharmaceutical | 3.52B |
| Harbin Medisan Pharmaceutical | 3.69B |
| PKU HealthCare Corp.,Ltd. | 3.75B |
| Baotou Dongbao Bio-Tech Co.,Ltd | 3.45B |